Glucagon-like peptide-1(7-36) amide enhances insulin-stimulated glucose uptake and decreases intracellular cAMP content in isolated rat adipocytes

被引:37
|
作者
Miki, H
Namba, M
Nishimura, T
Mineo, I
Matsumura, T
Miyagawa, J
Nakajima, H
Kuwajima, M
Hanafusa, T
Matsuzawa, Y
机构
[1] OTEMAE HOSP,OSAKA 540,JAPAN
[2] UNIV TOKUSHIMA,SCH MED,DEPT LAB MED,TOKUSHIMA 770,JAPAN
来源
关键词
glucagon-like peptide-1(7-36)amide; glucose uptake; cAMP; adipocyte; (rat);
D O I
10.1016/0167-4889(96)00032-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We investigated the effect of GLPs on glucose uptake in isolated rat adipocytes, GLP-1(7-36)amide significantly enhanced glucose uptake in the presence of 1 nM insulin. GLP-1(7-36)amide at 15 nM increased glucose uptake maximally by 56.4% as compared with 1 nM insulin alone (P < 0.01), In contrast, with less than 1 nM insulin or without insulin GLP-1(7-36)amide showed no effect on glucose uptake. Full-sequence GLP-1(1-37) at 15 nM in the presence of 1 nM insulin increased glucose uptake by 24.6% as compared with 1 nM insulin alone (P < 0.05). GLP-2 showed no effect on glucose uptake. Further, we examined the effect of GLP-1(7-36)amide on cAMP content in isolated rat adipocytes, Insulin at 1 nM caused a significant decrease of cAMP content, The combination of 15 nM GLP-1(7-36)amide and 1 nM insulin caused a further reduction of cAMP content. These data indicate that GLP-1(7-36)amide possesses augmentative effects on insulin action in isolated rat adipocytes. Furthermore, it is suggested that the stimulatory effect of GLP-1(7-36)amide occurs through the reduction of intracellular cAMP content.
引用
收藏
页码:132 / 136
页数:5
相关论文
共 50 条
  • [21] AUTORADIOGRAPHIC LOCALIZATION OF RECEPTORS FOR GLUCAGON-LIKE PEPTIDE-1(7-36) AMIDE IN RAT-BRAIN
    UTTENTHAL, LO
    TOLEDANO, A
    BLAZQUEZ, E
    [J]. NEUROPEPTIDES, 1992, 21 (03) : 143 - 146
  • [22] GLUCAGON-LIKE PEPTIDE-1 (7-36 AMIDE) - A POTENT GLUCAGONOSTATIC AND INSULINOTROPIC HORMONE
    MATSUYAMA, T
    KOMATSU, R
    NAMBA, M
    WATANABE, N
    ITOH, H
    TARUI, S
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 1988, 5 (04) : 281 - 284
  • [23] GLUCAGON-LIKE PEPTIDE-1(7-36)AMIDE RELAXES PULMONARY-ARTERIES
    FEDDERSEN, CO
    RICHTER, G
    GOKE, R
    GOKE, B
    WICHERTVON, P
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (04): : A138 - A138
  • [24] GLUCAGON-LIKE PEPTIDE-1 ENHANCES INSULIN-STIMULATED GLUCOSE-METABOLISM IN 3T3-L1 ADIPOCYTES
    EGAN, J
    MONTROSERAFIZADEH, C
    BERNIER, M
    ROTH, J
    [J]. CLINICAL RESEARCH, 1994, 42 (02): : A211 - A211
  • [25] EFFECTS OF GLUCAGON-LIKE PEPTIDE-1 (7-36) AMIDE AND GLUCAGON ON AMYLIN RELEASE FROM PERFUSED RAT PANCREAS
    INOUE, K
    HISATOMI, A
    UMEDA, F
    NAWATA, H
    [J]. HORMONE AND METABOLIC RESEARCH, 1991, 23 (09) : 407 - 409
  • [26] LUMINAL GLUCAGON-LIKE PEPTIDE-1(7-36) AMIDE-RELEASING FACTORS IN THE ISOLATED VASCULARLY PERFUSED RAT COLON
    PLAISANCIE, P
    DUMOULIN, V
    CHAYVIALLE, JA
    CUBER, JC
    [J]. JOURNAL OF ENDOCRINOLOGY, 1995, 145 (03) : 521 - 526
  • [27] THE ENTEROINSULAR AXIS - GLUCAGON-LIKE PEPTIDE-1(7-36)AMIDE (GLP-1(7-36)AMIDE) - A NEW INCRETIN CANDIDATE
    GOKE, R
    GOKE, B
    RICHTER, G
    ARNOLD, R
    [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 1988, 26 (11): : 715 - 719
  • [28] Effect of glucagon-like peptide 1 (7-36 amide) on insulin-mediated glucose uptake in patients with type 1 diabetes
    Meneilly, GS
    McIntosh, CHS
    Pederson, RA
    Habener, JF
    Ehlers, MRW
    Egan, JM
    Elahi, D
    [J]. DIABETES CARE, 2003, 26 (03) : 837 - 842
  • [29] Gene expression profiling of isolated islets of Langerhans treated with glucagon-like peptide-1 (7-36 amide)
    Nolan, AL
    Lechner, A
    Blacken, RA
    Habener, JF
    [J]. DIABETOLOGIA, 2004, 47 : A161 - A162
  • [30] GLUCAGON-LIKE PEPTIDE 1(7-36)AMIDE RECEPTORS IN THE LUNG
    RICHTER, G
    FEDDERSEN, O
    WAGNER, U
    LANKATBUTTGEREIT, B
    BARTH, P
    GOKE, R
    GOKE, B
    [J]. DIGESTION, 1993, 54 (06) : 344 - 344